Bài kiểm tra có liên kết hướng dẫn · Trung bình Cấp độ
EMA và AI trong bài kiểm tra quy định về thuốc
Kiểm tra trạng thái giấy phản ánh EMA, phạm vi vòng đời, bằng chứng về chức năng cụ thể, giám sát và phân biệt với ủy quyền sản phẩm.
Câu hỏi 1 của 8
Which statement describes the status of EMA’s AI reflection paper?
Xem trước mọi câu hỏi8 câu hỏi
Câu trả lời và giải thích xuất hiện khi bạn làm bài kiểm tra.
- Which statement describes the status of EMA’s AI reflection paper?
- It describes regulatory considerations but is not an AI product authorization
- It grants automatic approval to AI tools
- It replaces medicines legislation
- It is a standalone CE certificate
- Which stages of medicines work may involve AI?
- Only clinical diagnosis
- Only hospital billing
- Research, development, manufacturing, and medicine use
- Only marketing
- What should developers define before evaluating an AI function?
- The total number of data records
- Its intended purpose, context, users, and consequences of error
- Only its neural-network architecture
- The vendor’s product slogan
- Why does human oversight matter for higher-impact uses?
- It guarantees that the model is accurate
- It replaces data validation
- It makes change control unnecessary
- Qualified review and escalation help manage uncertain or erroneous outputs
- Which controls should accompany changes to an AI model over time?
- Versioning, change management, monitoring, and traceability
- Nothing if the model remains AI
- A new medicine approval for every typo
- A single performance report from development
- Does the reflection paper create one universal AI approval pathway?
- Yes, one pathway applies to every algorithm
- Yes, if the tool is used for medicine
- No AI use can be regulated
- No; existing requirements depend on the function and product
- How should clinical trial AI be documented?
- No details if the trial is blinded
- With data provenance, protocol alignment, validation, and limitations
- Only a vendor name
- Only the output score
- What should a sponsor consult before deploying AI in EU medicines work?
- A general AI product blog
- A prior model card regardless of use
- Current EMA and applicable EU guidance and legislation
- Only the reflection paper in isolation